QuinStreet Valuation
Is 5Q8 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 5Q8 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 5Q8 (€21.4) is trading below our estimate of fair value (€45.75)
Significantly Below Fair Value: 5Q8 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 5Q8?
Key metric: As 5Q8 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 5Q8's PS Ratio? | |
|---|---|
| PS Ratio | 1.7x |
| Sales | US$768.81m |
| Market Cap | US$1.29b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.7x |
| Enterprise Value/EBITDA | -282.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 5Q8's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4x | ||
NWO New Work | 1.2x | -4.1% | €367.6m |
G24 Scout24 | 10.8x | 8.0% | €6.2b |
SB1 Smartbroker Holding | 2.6x | 8.5% | €129.9m |
YOC YOC | 1.5x | 13.1% | €53.9m |
5Q8 QuinStreet | 1.7x | 16.3% | €1.3b |
Price-To-Sales vs Peers: 5Q8 is good value based on its Price-To-Sales Ratio (1.7x) compared to the peer average (4x).
Price to Sales Ratio vs Industry
How does 5Q8's PS Ratio compare vs other companies in the European Interactive Media and Services Industry?
| 7 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 7 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: 5Q8 is expensive based on its Price-To-Sales Ratio (1.7x) compared to the European Interactive Media and Services industry average (1.6x).
Price to Sales Ratio vs Fair Ratio
What is 5Q8's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.7x |
| Fair PS Ratio | 1.4x |
Price-To-Sales vs Fair Ratio: 5Q8 is expensive based on its Price-To-Sales Ratio (1.7x) compared to the estimated Fair Price-To-Sales Ratio (1.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €21.40 | €26.54 +24.0% | 9.5% | €29.29 | €22.88 | n/a | 5 |
| Nov ’25 | €19.20 | €21.12 +10.0% | 7.5% | €23.16 | €18.53 | n/a | 5 |
| Oct ’25 | €17.00 | €20.88 +22.8% | 7.5% | €22.90 | €18.32 | n/a | 5 |
| Sep ’25 | €17.00 | €20.88 +22.8% | 7.5% | €22.90 | €18.32 | n/a | 5 |
| Aug ’25 | €17.10 | €19.46 +13.8% | 7.2% | €20.49 | €16.76 | n/a | 5 |
| Jul ’25 | €15.20 | €19.46 +28.1% | 7.2% | €20.49 | €16.76 | n/a | 5 |
| Jun ’25 | €16.10 | €18.87 +17.2% | 6.9% | €20.26 | €16.57 | n/a | 5 |
| May ’25 | €15.90 | €15.31 -3.7% | 20.1% | €20.20 | €11.27 | n/a | 5 |
| Apr ’25 | €16.00 | €13.78 -13.9% | 14.9% | €16.53 | €11.02 | n/a | 4 |
| Mar ’25 | €13.50 | €14.48 +7.2% | 15.5% | €17.63 | €11.14 | n/a | 5 |
| Feb ’25 | €11.70 | €12.60 +7.7% | 23.1% | €17.35 | €9.13 | n/a | 5 |
| Jan ’25 | €11.90 | €12.50 +5.0% | 23.1% | €17.46 | €9.19 | n/a | 5 |
| Dec ’24 | €11.40 | €12.50 +9.6% | 23.1% | €17.46 | €9.19 | n/a | 5 |
| Nov ’24 | €10.60 | €9.70 -8.5% | 21.1% | €13.25 | €8.52 | €19.20 | 4 |
| Oct ’24 | €8.45 | €8.57 +1.5% | 5.1% | €9.19 | €8.27 | €17.00 | 3 |
| Sep ’24 | €9.10 | €8.57 -5.8% | 5.1% | €9.19 | €8.27 | €17.00 | 3 |
| Aug ’24 | €8.00 | €9.68 +21.0% | 8.8% | €10.89 | €9.07 | €17.10 | 3 |
| Jul ’24 | €8.00 | €9.68 +21.0% | 8.8% | €10.89 | €9.07 | €15.20 | 3 |
| Jun ’24 | €8.60 | €9.68 +12.5% | 8.8% | €10.89 | €9.07 | €16.10 | 3 |
| May ’24 | €9.95 | €15.78 +58.6% | 11.1% | €18.30 | €13.72 | €15.90 | 4 |
| Apr ’24 | €14.00 | €16.86 +20.4% | 10.4% | €18.73 | €14.05 | €16.00 | 4 |
| Mar ’24 | €15.90 | €16.86 +6.0% | 10.4% | €18.73 | €14.05 | €13.50 | 4 |
| Feb ’24 | €14.00 | €13.03 -6.9% | 18.5% | €16.41 | €9.65 | €11.70 | 4 |
| Jan ’24 | €13.00 | €13.03 +0.3% | 18.5% | €16.41 | €9.65 | €11.90 | 4 |
| Dec ’23 | €13.60 | €13.03 -4.2% | 18.5% | €16.41 | €9.65 | €11.40 | 4 |
| Nov ’23 | €11.50 | €12.20 +6.1% | 13.3% | €13.66 | €9.76 | €10.60 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Obiz
€24.3m
Provides relationship marketing and customer loyalty solutions in France and internationally.
2GD
€4.05
7D
-7.1%
1Y
-26.4%
illumin Holdings
CA$89.0m
A technology company, provides digital media solutions in the United States, Canada, Europe, Latin America, and internationally.
K3S0
CA$1.17
7D
-2.5%
1Y
20.6%
RTL Group
€3.7b
An entertainment company, operates television (TV) channels and radio stations, and provides streaming services in Germany, France, the Netherlands, Belgium, the United Kingdom, the United States, and internationally.
RRTL
€24.10
7D
0.4%
1Y
-28.8%